Search
for
Sort by
Research 91–120 of 1000+
- Telogen effluvium x female pattern hair loss: is there correlation?
- Evaluation of Thyroid Autoimmunity in Female Patients with Telogen Effluvium
- Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium
- Evaluation of the efficacy of a food supplement on subjects with acute telogen effluvium
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study
- Role of iron in telogen effluvium among premenopausal women
- Telogen Effluvium
- Presence of mast cells and mast cell degranulation in scalp biopsies of telogen effluvium
- Telogen Effluvium: A Review of the Literature
- Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non‐depilated mouse model
- Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- The Role of the VEGF, KGF, EGF, and TGF-β1 Growth Factors in the Pathogenesis of Telogen Effluvium in Women
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- Anagen Effluvium in Association With Extracorporeal Membrane Oxygenation
- Comparative evaluation of two Unani formulation combinations in the treatment of Telogen Effluvium: A randomized, single-blind clinical trial
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Platelet-Rich Plasma Therapy for Telogen Effluvium: A Comprehensive Evaluation of Efficacy and Safety
- Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19.
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
- Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3‐month, controlled, assessor‐blinded study
- Evaluation of Tolerance and Trichological Efficacy of a Food Supplement in Men and Women with Telogen Effluvium-like Disorder
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Alteration in Asbabe-Sitta-Zaruriyah (Six essential pre-requisite for maintaining health) to prevent Intithār al-Sha‘r (Telogen Effluvium): An Insight